Skip to content
TrialScanner

NCT02504489

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC

Phase 3CompletedBYSILead

Registry record

Lead sponsor
BeyondSpring Pharmaceuticals Inc.
Conditions
Non-Small Cell Lung Cancer
Primary completion
Jul 21, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02504489 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02504489: Docetaxel + Plinabulin... | TrialScanner